Dr. Chen Xiaoqing, the chief science officer of the company, has over ten years of experience in the scientific research and drug development field. Dr. Chen has garnered extensive practical research expertise in biological vectors, spanning from the utilization and engineering of HSV-1 vectors to the development of cutting-edge engineered exosome vectors. Dr. Chen has published 23 SCI articles in the fields of virology, oncology, and drug development and has 34 patent applications. As a project leader and key technical expert, she has hosted and participated in multiple national and municipal scientific research projects, including the National Major Scientific and Technological Special Project for Significant New Drugs Development (國家科技重大專項課題) during the Thirteenth Five-year Plan Period (“十三五”規劃), the National Natural Science Foundation (國家自然科學基金項目), and Guangdong Nature Science Foundation Major Provincial Scientific Research Project (Natural Sciences) for Higher Education Institutions in Guangdong Province” (廣東省高等學校省級重大科研項目(自然科學)).

Dr. Chen obtained her bachelor’s degree in biotechnology from Anhui University (安徽大學) in July 2009 and her doctor degree of science in biology from Nanjing University (南京大學) in June 2014. Dr. Chen has been a post-doctoral fellow in Guangzhou Medical University (廣州醫科大學) from November 2014 to October 2016.